Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • International
  • Clinic Portal
    • +0034963905310
  • Request Information
  • +34 96 390 53 10
InternationalInternational
  • International
  • We guide you
    • Fertility
      • What to do if…
    • Prevent Inherited Diseases
      • Carrier Genetic Test
    • Worry-free Pregnancy
      • NACE
      • Prenatal Diagnostics
      • Newborn Health
  • Reproductive Health
    • Specialists
      • ALICE
      • EMMA
      • ERA
      • EndomeTRIO
      • EMBRACE
      • CGT
      • NACE
      • PGT-A
      • PGT-M
      • POC
      • SAT
      • Newborn Screening
    • Patients
      • ALICE
      • EMMA
      • ERA
      • EndomeTRIO
      • EMBRACE
      • CGT
      • NACE
      • PGT-A
      • PGT-M
      • SAT
      • POC
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
  • Webinars
  • Blog

NEW INDEPENDENT ERA PUBLICATION

ERA-guided pETs significantly improves pregnancy rates compared to conventional FETs

Go to the abstract

ENDOMETRIAL MICROBIOTA COMPOSITION IS ASSOCIATED WITH REPRODUCTIVE OUTCOME IN INFERTILE PATIENTS

A new study led by Dr. Inmaculada Moreno shows that endometrial microbiota composition before embryo transfer is an useful biomarker to predict reproductive outcome, offering an opportunity to further improve diagnosis and treatment strategies.

Go to the publication Watch our summary video



          Dr. Inma Moreno 
     Microbiome Jr Director

Vitrolife completes THE acquisition of Igenomix

Together, we create a global leader in reproductive health

It is with great pleasure that we can communicate Vitrolife AB has concluded the acquisition of Igenomix. The two separate companies will continue operating independently but, by combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we will be able to better support clinics and patients across the fertility journey.

Visit Vitrolife website

Vitrolife completes the acquisition of Igenomix

Together, we create a global leader in reproductive health

It is with great pleasure that we can communicate Vitrolife AB has concluded the acquisition of Igenomix. The two separate companies will continue operating independently but, by combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we will be able to better support clinics and patients across the fertility journey

Visit Vitrolife website

+460
SCIENTIFIC
PUBLICATIONS

26
LABS
WORLDWIDE

+550
PROFESSIONALS

EndomeTRIO

+6
PATENTS

Genetic Solutions for Specialists

Igenomix offers pioneering tests to help reproductive health professionals diagnose and treat their patients.

Preconception

Detect genetic abnormalities before treatment

More information
Igenomix preimplantation

Preimplantation

Help your patient avoid implantation failure

More information
POC Products of Conception

Prenatal

Ensure your patient has a healthy pregnancy

More information
See all services

We guide you

We can help to guide your journey and develop your understanding:

Igenomix fertility

Fertility

In this section, you’ll find educational content which may help, whatever your reproductive journey

More information

Inherited diseases

Prevent the transmission of single gene disorders in a family and achieve a healthy pregnancy

More information
Igenomix healthy pregnancy

Healthy pregnancy

Enjoy a worry-free pregnancy

More information
See all services

Research and Igenomix Foundation

Igenomix Foundation

Igenomix CEO

Our vision and passion is the translation of scientific knowledge to reproductive medicine; supporting clinicians and patients using an evidence-based approach.

Igenomix Research

Igenomix

Providing solutions to professionals working in reproductive medicine.

Foundation news

european fertility week 2021
European Fertility Week 2021
2 November, 2021
Igenomix Foundation

About Igenomix

Igenomix is a medical testing laboratory specializing in reproductive genetic services.
We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility specialists worldwide, we investigate human reproduction to change the lives of those who are trying to conceive.

Learn more about Igenomix
How to send a sample?

WE GUIDE YOU

Fertility
Inherited diseases prevention
Healthy pregnancy

To see the accreditation certificate, associated technical annex and list of accredited tests, click on this link.

OUR SERVICES

Genetic solutions
For patients
How to send a sample?
User manual

ABOUT US

About Igenomix
Contact
Quality
Complaints
Work with us

FOLLOW IGENOMIX

  + 96 390 53 10
  Write us
  • Argentina
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
Europe

[2021] © Igenomix Privacy policy Quality policy Legal note Cookies policy     News and Press   

Request Information


  • reCAPTCHA demo: Simple page

  • We guide you
    • Fertility
      • What to do if…
    • Prevent Inherited Diseases
      • Carrier Genetic Test
    • Worry-free Pregnancy
      • NACE
      • Prenatal Diagnostics
      • Newborn Health
  • Reproductive Health
    • Specialists
      • ALICE
      • EMMA
      • ERA
      • EndomeTRIO
      • EMBRACE
      • CGT
      • NACE
      • PGT-A
      • PGT-M
      • POC
      • SAT
      • Newborn Screening
    • Patients
      • ALICE
      • EMMA
      • ERA
      • EndomeTRIO
      • EMBRACE
      • CGT
      • NACE
      • PGT-A
      • PGT-M
      • SAT
      • POC
  • Diagnostics
  • About us
    • Igenomix Research
    • About Igenomix
  • Webinars
  • Blog
  • International
  • +34 96 390 53 10
  • Clinic Portal
  • Request Information